Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cough med marketers add icon to label

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association says cough medicine marketers have added an educational icon to product labels to alert consumers of the danger of OTC drug abuse and direct them to the Web site, which provides resources for talking to teens about the issue. In addition, CHPA reported that Dr. Drew Pinsky, host of the radio show "Loveline" and star of the VH1 hits "Celebrity Rehab with Dr. Drew" and "Sober House," has joined CHPA's "Five Moms" public health campaign to prevent teen abuse of cough medicine (1"The Tan Sheet" May 14, 2007)

You may also be interested in...

CHPA’s “Five Moms” Uses Web To Lead Latest Public Service Campaign

The Consumer Healthcare Products Association encourages parents to help stop abuse of cough and cold medicines through online networking, the same means by which young people learn to abuse the substances

New EU Approvals

The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include two new products, including Blueprint Medicines' Ayvakyt for treating unresectable or metastatic gastrointestinal stromal tumors. The list, which contains information dating back to January 2018, comprises brand name, generic name, company, therapeutic indication, date of marketing authorization announcement and product type (eg, medicine, vaccine, biologic).

EU Biosimilar Filings, Opinions And Approvals

A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts